PEOPLE - Guava Technologies makes appointment:
This article was originally published in Clinica
Cell analysis system provider Guava Technologies (Hayward, California) has appointed David Ferrick to the position of vice-president of biology and clinical applications. Previously, Mr Ferrick served as CEO and director of Sagres Discovery, an onco-genome research and cancer company, which he co-founded in 1999.
You may also be interested in...
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.